Articles Tagged With:
-
B-type Natriuretic Peptide Is Less Useful in Elderly Patients With Dyspnea
Among patients ≥ 80 years of age presenting with acute dyspnea, B-type natriuretic peptide level was not useful for differentiating cardiac vs. respiratory etiologies when added to a model of clinical predictors.
-
Distinguishing Ischemic From Non-ischemic Cardiomyopathy Clinically
The authors of a recent study concluded that specific clinical and ECG abnormalities could be used to estimate which patients with reduced left ventricular ejection fraction were at low risk of having ischemic cardiomyopathy.
-
Antiplatelet Therapy After TAVR: More ARTE Than Science
The current clinical standard of dual antiplatelet therapy following transcatheter aortic valve replacement is controversial.
-
Late-breaking Clinical Trials from the Heart Rhythm Society May 2017 Scientific Sessions
Late-breaking findings of several important clinical trials were presented at this year’s Heart Rhythm Society Scientific Sessions in Chicago. A selection particularly relevant to the general cardiology community is presented here.
-
Are There Definitive Clues?
How certain are you that the run of wide complex tachycardia that begins with beat #4 is ventricular tachycardia?
-
Encephalitis Due to Powassan Virus
Powassan virus is transmitted by the same tick that carries the etiologic agent of Lyme disease and several other pathogens. The number of cases of encephalitis caused by this virus may be increasing in the endemic areas.
-
Ready for Dengue in the United States?
Dengue is increasingly recognized in the southern United States. When recently surveyed, however, clinicians in Texas seemed incompletely prepared to understand and manage patients with dengue.
-
Infective Endocarditis Trends and Outcomes
Using large databases from New York and California, investigators found the overall incidence of infective endocarditis remained stable between 1998 and 2013, and 90-day mortality declined. Changes were noted in pathogen etiology and patient characteristics over time.
-
HCV: Is It Better to Test and Treat Than Try PEP?
Despite – or perhaps because of -- the incredible cure rates being achieved by new drugs for hepatitis C virus, experts say post-exposure prophylaxsis for exposed healthcare workers is not the path to pursue. Given a host of undermining variables, it is better to repeatedly test a worker who suffers a needlestick, ready to treat as soon as a seroconversion occurs, experts concur.
-
For Everything There Is a Season – Including SSIs?
While it is way too early to advise patients to have elective surgery in the dead of winter, researchers are unraveling some telling indications that surgical site infections are much more likely to occur in the hottest months of the year.